These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias. Masterman D Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487 [No Abstract] [Full Text] [Related]
5. [Current antidementive therapy]. Perneczky R; Kurz A MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702 [TBL] [Abstract][Full Text] [Related]
6. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
7. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine. Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773 [TBL] [Abstract][Full Text] [Related]
8. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
9. Alternative drug therapies for dementia. Howland RH J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703 [TBL] [Abstract][Full Text] [Related]
10. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population. Prasher VP Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527 [TBL] [Abstract][Full Text] [Related]
11. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276 [No Abstract] [Full Text] [Related]
13. Cholinesterase inhibitors and Gingko extracts--are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Wettstein A Phytomedicine; 2000 Jan; 6(6):393-401. PubMed ID: 10755847 [TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Kurz A; Van Baelen B Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date. Bullock R Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232 [TBL] [Abstract][Full Text] [Related]
16. [To differentiate Alzheimer's and vascular dementia? Today no longer up to date]. Wettstein A MMW Fortschr Med; 2001 Dec; 143(51-52):41-2. PubMed ID: 11824166 [No Abstract] [Full Text] [Related]
17. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522 [TBL] [Abstract][Full Text] [Related]
18. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032 [TBL] [Abstract][Full Text] [Related]